Finding 399888 (2023-003)

Material Weakness
Requirement
ABL
Questioned Costs
-
Year
2023
Accepted
2024-06-04

AI Summary

  • Core Issue: The Authority reported inflated expenses related to COVID-19 by not deducting Medicare reimbursements, leading to a material error in their report.
  • Impacted Requirements: Compliance with CFR 200.303(a) was not met due to inadequate internal controls over expense reporting.
  • Recommended Follow-Up: Revise internal control policies to ensure claimed expenses are properly adjusted for any Medicare reimbursements.

Finding Text

Department of Health and Human Services Federal Assistance Listing #93.498 COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Applicable Federal Award Number and Year – Period 4 TIN #736060835 Activities Allowed or Unallowed, Allowable Cost/Cost Principles, and Reporting Material Weakness in Internal Control Over Compliance and Material Noncompliance Related to Reporting Criteria: CFR 200.303(a) establishes that the auditee must establish and maintain effective internal control over the federal award that provides assurance that the entity is managing the federal award in compliance with federal statutes, regulations, and conditions of the federal award. Condition: The Authority is a critical access hospital and reimbursed from Medicare based on the expenses incurred to treat Medicare beneficiaries for the majority of operating activities. The Authority claimed expenses attributable to coronavirus but did not reduce such expense by the amounts Medicare reimburses or is obligated to reimburse the Authority. As a result, the Authority's Period 4 report to the Department of Health and Human Services (HHS) contained a material error in one of the key line items. Cause: The Authority did not have adequate internal controls policy in place to ensure expenses claimed were being reduced by Medicare's reimbursement. Effect: The Authority claimed and reported expenses that were reimbursed or obligated to be reimbursed by Medicare. Questioned Costs: None. While expenses were overstated by $179,554, the Authority had adequate other expenditures and lost revenues included on the Period 4 report to HHS to substantiate the amounts received in Period 4. Context: The Authority claimed expenses attributable to coronavirus totaling $835,781. The Authority's estimate of reimbursement from Medicare for costs incurred was based on the Medicare utilization from the 2022 and 2023 annual cost report. This methodology was applied to all costs incurred in determining the total amount of $179,544 considered to be reimbursed by another source. While sampling was used to test expenditures, it was not used to identify or calculate the error. All key line items on the Period 4 report to HHS were subject to testing for reporting. Repeat Finding from Prior Years: No Recommendation: We recommend the Authority modify internal control policies to ensure amounts claimed for this program are reduced by amounts reimbursed or obligated to be reimbursed by another source, including Medicare cost-based reimbursement. Views of Responsible Officials: Management agrees with the finding.

Corrective Action Plan

Activities Allowed or Unallowed, Allowable Cost/Cost Principles, and Reporting Finding 2023-003 Federal Agency Name: Department of Health and Human Services Assistance Listing Number: 93.498 Program Name: COVDI-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Finding Summary: activities. The Authority claimed expenses attributable to coronavirus but did not reduce such expense by the amounts Medicare reimburses or is obligated to reimburse the Authority. Corrective Action Plan: The Authority has enhanced the internal controls to ensure underlying supporting records agree to the final reports submitted to HHS, including a review and approval by someone different than the individual inputting the report data. Responsible Individual: Priacilla Leatherman, VP of Finance Anticipated Completion Date: May 2024

Categories

Allowable Costs / Cost Principles Cash Management Material Weakness Reporting

Other Findings in this Audit

  • 399889 2023-004
    Material Weakness
  • 399890 2023-005
    Significant Deficiency Repeat
  • 976330 2023-003
    Material Weakness
  • 976331 2023-004
    Material Weakness
  • 976332 2023-005
    Significant Deficiency Repeat

Programs in Audit

ALN Program Name Expenditures
10.766 Community Facilities Loans and Grants $2.37M
93.498 Provider Relief Fund $1.49M
93.697 Covid-19 Testing for Rural Health Clinics $331,980
93.155 Rural Health Research Centers $261,068
93.301 Small Rural Hospital Improvement Grant Program $11,520